Novartis CEO discusses how AI will impact drug development

  Рет қаралды 11,457

Yahoo Finance

Yahoo Finance

Күн бұрын

Пікірлер: 4
@WhereTechMeetsBio
@WhereTechMeetsBio 10 ай бұрын
How he is so sure AI won't impact early drug discovery within 5 years? We will have clinical trial stats on AI-designed candidates within next 2-4 years and companies like Insilico Medicine are showing already today that it is possible to get results with AI quickly and for more tx areas at once.
@squamish4244
@squamish4244 6 ай бұрын
AI has already created a potential new drug, a year ago, for liver cancer. So maybe he's being conservative in his estimates. Or maybe the pipeline really is that long due to human trials and it will taken ten years to produce a bunch of new drugs. I'd be very surprised if in ten years, we do NOT have a bunch of new AI-discovered drugs, however.
@MuhammadAlcantara
@MuhammadAlcantara Ай бұрын
what a poor guy 😢
@solidhg2005
@solidhg2005 3 ай бұрын
What pipeline, how does it even run out?
Novartis CEO Vas Narasimhan on The David Rubenstein Show
24:07
David Rubenstein
Рет қаралды 37 М.
How AI is Redefining Drug Discovery
22:49
SandboxAQ
Рет қаралды 1,9 МЛН
How Strong Is Tape?
00:24
Stokes Twins
Рет қаралды 96 МЛН
The Best Band 😅 #toshleh #viralshort
00:11
Toshleh
Рет қаралды 22 МЛН
An AI Drug Discovery Stock We Like
16:18
Nanalyze
Рет қаралды 13 М.
Introduction to Module 6 with Dr. William Zamboni
19:03
NIH Clinical Center
Рет қаралды 47 М.
Towards Rational Drug Design with AlphaFold 3 | Max Jaderberg
50:28
Valence Labs
Рет қаралды 2,1 М.
Generative AI in a Nutshell - how to survive and thrive in the age of AI
17:57